HC Surgical Specialists : Resolutions Passed at the Annual General Meeting held on 28 September 2021 Download PDF

HC SURGICAL SPECIALISTS LIMITED

Incorporated in the Republic of Singapore

Registration No. 201533429G

RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING HELD ON 28 SEPTEMBER 2021

Capitalised terms used herein, unless otherwise defined, shall have the definitions ascribed to them in the annual report of the Company for the financial year ended 31 May 2021 ("AR2021") and the appendix to the AR2021 which were despatched to shareholders of HC Surgical Specialists Limited (the "Company") on 6 September 2021.

The Board of Directors of the Company is pleased to announce that, pursuant to Rule 704(15) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist (the "Catalist Rules"), all of the resolutions set out in the Notice of the Annual General Meeting ("AGM") dated 6 September 2021 were duly passed by way of poll, at the AGM held on 28 September 2021, by way of electronic means.

1. The results of the poll on the resolutions put to the vote at the AGM are as follows:-

							For		Against
						Total number			As a		As a
								percentage		percentage
						of shares
								of total		of total
						represented
Resolution number and			number of		number of
by votes for	Number of		Number
		details				votes for	votes for
				and against	shares		of shares
							and against	and against
						the relevant
								the		the
						resolution
								resolution		resolution
									(%)		(%)
Ordinary Business
1	Re-election	of	Mr.
	Chong	Weng	Hoe
	as	Director of	the	110,442,259	110,442,259		100.00	0	0.00
	Company(1)
2	Re-election	of	Dr.
	Chia Kok Hoong as
	Director		of	the	110,442,259	110,442,259		100.00	0	0.00
	Company(2)
3	Directors'	Fees of
	S$111,000/- for the
	financial year ended	110,442,259	110,442,259		100.00	0	0.00
	31 May 2021
4	Declaration	of	final
	dividend			(tax-
	exempt one-tier) of	110,442,259	110,442,259		100.00	0	0.00
	S$0.023			per
	ordinary	share	for
	the	financial	year
	ended 31 May 2021

						For		Against
					Total number			As a		As a
							percentage		percentage
					of shares
							of total		of total
					represented
Resolution number and			number of		number of
by votes for	Number of		Number
		details			votes for	votes for
			and against	shares		of shares
						and against	and against
					the relevant
							the		the
					resolution
							resolution		resolution
								(%)		(%)
Ordinary Business
5		Re-appointment of
		Messrs BDO LLP as
		auditors	of	the	110,442,259	110,442,259		100.00	0	0.00
		Company
Special Business
6		Authority	to	issue	110,442,259	110,442,259		100.00	0	0.00
		ordinary shares
7		Authority	to	issue
		shares	under	the	110,442,259	110,442,259		100.00	0	0.00
		HCSS Performance
		Share Plan
8		Authority	to	issue
		shares	under	the
		HCSS	Employee	110,442,259	110,442,259		100.00	0	0.00
		Share	Option
		Scheme
9		Proposed Renewal
		of the Share	Buy-	46,453,279	46,453,279		100.00	0	0.00
		Back Mandate
Notes:

1. 1. Mr. Chong Weng Hoe, who was re-elected as a Director under Resolution 1, remains as the Chairman of the Board, the Remuneration Committee and Nominating Committee, and a member of the Audit Committee of the Company. He is considered independent for the purpose of Rule 704(7) of the Catalist Rules.
   2. Dr. Chia Kok Hoong, who was re-elected as a Director under Resolution 2, remains as the Executive Director and Medical Director of the Company.
2. Details of the party who had abstained from voting on Resolution 9 and his shareholdings is as follows:-

Name	Number of shares held
1. Dr. Heah Sieu Min	63,988,980

1. Name of firm appointed as Scrutineer:
   Entrust Advisory Pte. Ltd. was appointed as the scrutineer for the AGM.

By Order of the Board

Dr. Heah Sieu Min

Executive Director and Chief Executive Officer

Date: 28 September 2021

About HC Surgical Specialists Limited

HC Surgical Specialists Limited (the "Company") was incorporated on 1 September 2015 in Singapore and listed on Catalist of the Singapore Exchange Securities Trading Limited on 3 November 2016. The Company, its subsidiaries and associated company are a medical services group primarily engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of 18 clinics located throughout Singapore.

This announcement has been prepared by the Company and reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. (the "Sponsor"), in compliance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.

The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone [phone].